An overview of sleep and circadian dysfunction in Parkinson's disease
- 1 March 2018
- journal article
- review article
- Published by Wiley in Journal of Sleep Research
- Vol. 27 (3) , e12673
Abstract
Summary: Sleep and circadian alterations are amongst the very first symptoms experienced in Parkinson's disease, and sleep alterations are present in the majority of patients with overt clinical manifestation of Parkinson's disease. However, the magnitude of sleep and circadian dysfunction in Parkinson's disease, and its influence on the pathophysiology of Parkinson's disease remains often unclear and a matter of debate. In particular, the confounding influences of dopaminergic therapy on sleep and circadian dysfunction are a major challenge, and need to be more carefully addressed in clinical studies. The scope of this narrative review is to summarise the current knowledge around both sleep and circadian alterations in Parkinson's disease. We provide an overview on the frequency of excessive daytime sleepiness, insomnia, restless legs, obstructive apnea and nocturia in Parkinson's disease, as well as addressing sleep structure, rapid eye movement sleep behaviour disorder and circadian features in Parkinson's disease. Sleep and circadian disorders have been linked to pathological conditions that are often co‐morbid in Parkinson's disease, including cognitive decline, memory impairment and neurodegeneration. Therefore, targeting sleep and circadian alterations could be one of the earliest and most promising opportunities to slow disease progression. We hope that this review will contribute to advance the discussion and inform new research efforts to progress our knowledge in this field.Keywords
Funding Information
- Advance Queensland
This publication has 274 references indexed in Scilit:
- REM Sleep Behavior Disorder and REM Sleep Without Atonia as an Early Manifestation of Degenerative Neurological DiseaseCurrent Neurology and Neuroscience Reports, 2012
- Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based studyAnnals of Neurology, 2011
- Restless legs syndrome and Parkinson's disease in menMovement Disorders, 2010
- Sleep in Parkinson's disease: A comparison of actigraphy and subjective measuresParkinsonism & Related Disorders, 2010
- Good night and good luck: Norepinephrine in sleep pharmacologyBiochemical Pharmacology, 2010
- Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorderPsychoneuroendocrinology, 2008
- Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body diseaseSleep Medicine, 2007
- Writing narrative literature reviews for peer-reviewed journals: secrets of the tradeJournal of Chiropractic Medicine, 2006
- Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1Proceedings of the National Academy of Sciences, 2006
- A community‐based study of sleep disorders in patients with Parkinson's diseaseMovement Disorders, 1998